Benitec Biopharma (BNTC) Assets Average (2020 - 2025)
Historic Assets Average for Benitec Biopharma (BNTC) over the last 6 years, with Q1 2025 value amounting to $92.1 million.
- Benitec Biopharma's Assets Average rose 40692.4% to $92.1 million in Q1 2025 from the same period last year, while for Mar 2025 it was $92.1 million, marking a year-over-year increase of 40692.4%. This contributed to the annual value of $28.3 million for FY2024, which is 44301.04% up from last year.
- Benitec Biopharma's Assets Average amounted to $92.1 million in Q1 2025, which was up 40692.4% from $73.9 million recorded in Q4 2024.
- Benitec Biopharma's 5-year Assets Average high stood at $92.1 million for Q1 2025, and its period low was $6.3 million during Q2 2023.
- Over the past 5 years, Benitec Biopharma's median Assets Average value was $15.9 million (recorded in 2021), while the average stood at $26.4 million.
- Per our database at Business Quant, Benitec Biopharma's Assets Average tumbled by 5392.59% in 2022 and then soared by 42987.23% in 2024.
- Benitec Biopharma's Assets Average (Quarter) stood at $15.9 million in 2021, then fell by 5.75% to $15.0 million in 2022, then soared by 61.25% to $24.2 million in 2023, then soared by 205.42% to $73.9 million in 2024, then increased by 24.64% to $92.1 million in 2025.
- Its Assets Average stands at $92.1 million for Q1 2025, versus $73.9 million for Q4 2024 and $60.5 million for Q3 2024.